Filter Search


Healthcare and Medical


Location Summary Deadline
Germany Completion Of A Non -excessive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Lamivudin + Dolutegravir, Atc J05ar25 For The Time 01.07.2025 30.2027 2025-11-18
Germany Completion Of A Non -excessive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Epinephrin, Atc C01ca24 For The Time 01.07.2025 30.06.2027 (plus Extension Option 1x12 Months) 2025-11-18
Germany Completion Of A Non -excessive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Lapatinib, Atc L01eh01 For The Time 01.07.2025 30.06.2027 (plus Extension Option 1x 12 Months) 2025-11-18
Germany Completion Of A Non -excessive Discount Agreement According To § 130a Para. 8 Sgb V To The Active Ingredient Saproptera (exclusively Dosage Form Ple), Atc A16ax07 For The Time 01.07.2025 30.2027 2025-11-18
Germany Completion Of Non -existing Discount Agreements According To § 130 A Para. 8 Sgb V With The Active Ingredient Epoetin Zeta 2025-11-18
Canada Participant Of Cybera Shareit Buying Group 2025-11-18
Norway Heart Sling Machine For St.olavs Hospital 2025-11-18
Germany Completion Of A Non -excessive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Rilpivirin, Atc J05ag05 For The Time 01.07.2025 30.06.2027 2025-11-19
Germany Completion Non -existing Discount Agreements According To § 130a Para. 8 Sgb V (openhousemodell) 2025-11-19
Germany Completion Of A Non -excessive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Cyanocobalamine, Atc B03ba01 For The Time 01.07.2025 30.06.2027 (plus Extension Option 1x 12 Months) 2025-11-19
Whats app